Tamoxifen 10mg/tab 30 Tabletten by Sopharma

Usage

1. Identify the specific compound(s) you ran — the ester type and suppression profile of each substance determines both your PCT start date and your opening Tamoxifen dose.
2. Allow the appropriate washout period before your first tablet: roughly 3–5 days for short-ester testosterone, 10–14 days for long-ester injectables, 21–28 days for Nandrolone Decanoate, and as little as 24 hours for oral-only cycles.
3. Confirm biochemical readiness where possible — a serum LH reading below 1.0 mIU/mL alongside low-normal total testosterone on bloodwork supports the decision to begin SERM therapy.
4. Take your daily Tamoxifen Citrate dose as whole tablets — the 10 mg denomination allows multi-tablet dosing at every phase without cutting, preserving dose accuracy.
5. Administer consistently at the same time each day; Tamoxifen's extended plasma half-life of approximately five to seven days means steady-state is maintained, but daily timing consistency supports predictable hormone feedback dynamics.
6. Schedule a follow-up bloodwork panel (LH, FSH, total testosterone, estradiol) at the midpoint and end of your protocol — compound-specific recovery timelines vary, and bloodwork is the only reliable indicator that your axis has genuinely restored.

Warnings

Frequently asked questions

What PCT protocol does Sopharma Tamoxifen 10mg suit after a Trenbolone cycle?

Trenbolone's deep androgenic and partial progestogenic suppression demands a longer, more sustained SERM protocol than testosterone-only cycles. Most practitioners apply 40 mg/day (4 tablets) for weeks one and two, then 20 mg/day for weeks three through six, monitoring LH and FSH by bloodwork. The 10 mg denomination allows precise stepwise dose adjustment across all six weeks without splitting tablets.

Is the PCT approach after a straight testosterone cycle different from a 19-nor compound cycle?

Yes — meaningfully so. A testosterone-only cycle leaves gonadotroph cells suppressed but reactive; Tamoxifen Citrate typically restores LH output within two weeks. 19-nor compounds like Trenbolone and Nandrolone create a slower-releasing suppression with residual activity that outlasts the parent compound, requiring a longer SERM engagement period and close bloodwork monitoring to confirm genuine axis recovery.

When should I start Tamoxifen after a Nandrolone Decanoate (Deca) cycle, and why does timing differ?

Deca's decanoate ester has a release half-life of roughly 7–12 days, and its primary metabolite 19-norandrosterone remains detectable — and suppressive — for several weeks after the last injection. Starting Tamoxifen while residual Nandrolone metabolites are still biologically active is counterproductive. Standard practice is to wait 3–4 weeks after the final Deca injection before beginning SERM therapy, confirmed where possible by a suppressed LH reading.

What makes Sopharma's 10 mg tablet the practical choice for compound-specific PCT dose adjustments?

The 10 mg denomination is the lowest available in this product batch, giving users the finest granularity for tapering across multi-phase PCT designs. Compound-specific protocols often require dose reductions at two-week intervals; with 10 mg whole tablets, each step down is clean and accurate — no tablet cutting, no content variance introduced by splitting.

Do oral-only cycles require the same Tamoxifen dose intensity as injectable compound cycles?

No — oral-only cycles generally produce a shallower suppression than long-ester injectable stacks, and rapid plasma clearance of oral compounds allows SERM introduction almost immediately after the final dose. A three-to-four week Tamoxifen protocol at 20 mg/day (two 10 mg tablets) is typically sufficient, compared to the six-to-twelve week plans that heavy injectable or 19-nor cycles may require. (2) angle_used

Manufacturer

Sopharma AD, headquartered in Sofia, Bulgaria, operates one of the European Union's fully licensed large-scale pharmaceutical manufacturing sites, with EU GMP certification spanning solid oral dosage form production through to finished-product release. The facility's scope covers the full manufacturing sequence — API receipt and testing, controlled blending, tablet compression, and blister sealing — all performed within environmentally monitored production suites subject to regulatory inspection. Released batches of Tamoxifen Citrate tablets are validated against declared potency using HPLC methodology and assessed for endotoxin burden via LAL testing, providing dual analytical assurance that each 10 mg tablet delivered to the end user meets pharmaceutical-grade specification.